血漿分餾市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

到 2022 年，全球血漿分離市場規模將達到 238 億美元。 展望未來，IMARC Group 預計到 2028 年將達到 337 億美元，2023 年至 2028 年的增長率 (CAGR) 為 5.8%。

血漿分離是指將捐贈的血漿下游加工成救生療法和藥物。 使用機械分離方法（例如離心、深層過濾、沉降和層析）將血漿分解成單個蛋白質或血漿組分。 幾種現代分餾工藝現在使用酒精濃度、時間、溫度和 pH 值來提取特定的治療性蛋白質。 此外，多年來技術的成熟和過程中病毒減少過程的引入使得新的蛋白質療法得以開發並提高了產品純度和質量。

血漿分餾市場趨勢

• 從人血漿中分離出的蛋白質產品具有重要意義，廣泛用於預防、管理和治療危及生命的疾病，例如傳染病、出生缺陷、罕見血液病、免疫紊亂和自身免疫性疾病。它是一種治療性藥物藥品。 全球這些疾病患病率的顯著增加是推動市場增長的關鍵因素之一。 此外，製造商正在通過實施嚴格的法規和各國政府機構制定的有關生物製品質量保證的標準管理和製定來促進高安全性血漿組分的開發。 另外，市場參與者正在投資研發 (R&D) 以推出血漿生產技術的進步，以提高產品功效並增強免疫球蛋白 G (IgG) 的回收率以分離新的血漿蛋白。）資助活動。 此外，我們還專注於開發廉價的病毒滅活和處理技術，使當地的血漿資源可以安全使用。 這一點，再加上對提高產量、保持工藝經濟性和收緊監管要求的需求不斷增長，預計將在未來幾年提供良好的市場前景。

主要市場細分

• IMARC Group 分析了全球血漿分餾市場報告每個子細分市場的主要趨勢，並提供了 2023 年至 2028 年全球、區域和國家層面的預測。 該報告根據產品、細分市場、應用程序和最終用戶對市場進行分類。

按產品細分

• 免疫球蛋白
• 白蛋白
• 凝血因子 VIII
• 凝血因子 IX

按部門細分

• 私營部門
• 公共部門

按應用細分

• 神經區域
• 免疫學
• 血液學
• 其他應用

最終用戶細分

• 醫院和診所
• 臨床研究所
• 學術機構

按地區劃分

• 北美
• 美國
• 加拿大
• 亞太地區
• 中國
• 日本
• 印度
• 韓國
• 澳大利亞
• 印度尼西亞
• 其他
• 歐洲
• 德國
• 法國
• 英國
• 意大利
• 西班牙
• 俄羅斯
• 其他
• 拉丁美洲
• 巴西
• 墨西哥
• 其他
• 中東和非洲

內容

第一章前言

第 2 章研究方法和範圍

• 調查的目的
• 利益相關者
• 數據源
  • 主要信息
  • 次要信息
• 市場評估
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第 3 章執行摘要

第四章介紹

• 概覽
• 主要行業趨勢

第 5 章全球血漿分餾市場

• 市場概覽
• 市場結果
• COVID-19 的影響
• 市場預測

第 6 章按產品劃分的市場細分

• 免疫球蛋白
  • 市場趨勢
  • 市場展望
• 白蛋白
  • 市場趨勢
  • 市場展望
• 凝血因子 VIII
  • 市場趨勢
  • 市場預測
• 凝血因子 IX
  • 市場趨勢
  • 市場預測

第 7 章按行業劃分的市場細分

• 私營部門
  • 市場趨勢
  • 市場預測
• 公共部門
  • 市場趨勢
  • 市場展望

第 8 章按應用劃分的市場細分

• 神經學
  • 市場趨勢
  • 市場展望
• 免疫學
  • 市場趨勢
  • 市場預測
• 血液學
  • 市場趨勢
  • 市場預測
• 其他應用
  • 市場趨勢
  • 市場預測

第 9 章最終用戶的市場細分

• 醫院和診所
  • 市場趨勢
  • 市場預測
• 臨床研究所
  • 市場趨勢
  • 市場預測
• 學術機構
  • 市場趨勢
  • 市場預測

第 10 章區域市場細分

• 北美
  • 美國
    • 市場趨勢
    • 市場預測
  • 加拿大
    • 市場趨勢
    • 市場展望
• 亞太地區
  • 中國
    • 市場趨勢
    • 市場展望
  • 日本
    • 市場趨勢
    • 市場展望
  • 印度
    • 市場趨勢
    • 市場展望
  • 韓國市場
    • 市場趨勢
    • 市場展望
  • 澳大利亞
    • 市場趨勢
    • 市場展望
  • 印度尼西亞
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 歐洲
  • 德國
    • 市場趨勢
    • 市場展望
  • 法國
    • 市場趨勢
    • 市場預測
  • 英國
    • 市場趨勢
    • 市場預測
  • 意大利
    • 市場趨勢
    • 市場展望
  • 西班牙
    • 市場趨勢
    • 市場展望
  • 俄羅斯
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 拉丁美洲
  • 巴西
    • 市場趨勢
    • 市場展望
  • 墨西哥
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 中東和非洲
  • 市場趨勢
  • 按國家/地區劃分的市場細分
  • 市場展望

第 11 章 SWOT 分析

• 概覽
• 強度
• 弱點
• 機會
• 威脅

第12章價值鏈分析

第13章搬運工五力分析

• 概覽
• 買家的議價能力
• 供應商的議價能力
• 競爭程度
• 新進入者的威脅
• 替代品的威脅

第14章價格分析

第15章競爭格局

• 市場結構
• 主要公司
• 主要公司簡介
  • ADMA Biologics
  • Bio Products Laboratory Ltd.
  • Boccard
  • Grifols, S.A.
  • Hemarus Therapeutics Limited
  • Intas Pharmaceuticals Limited
  • LFB S.A.
  • Merck Group
  • Octapharma AG
  • PlasmaGen BioSciences Pvt. Ltd.
  • SK Plasma Co. Ltd.
  • Virchow Biotech Private Limited

The global plasma fractionation market size reached US$ 23.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.

Plasma Fractionation Market Trends:

• Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.

Key Market Segmentation:

• IMARC Group provides an analysis of the key trends in each sub-segment of the global plasma fractionation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, sector, application and end user.

Breakup by Product:

• Immunoglobulins
• Albumin
• Coagulation factor VIII
• Coagulation factor IX

Breakup by Sector:

• Private Sector
• Public Sector

Breakup by Application:

• Neurology
• Immunology
• Hematology
• Other Applications

Breakup by End User:

• Hospitals and Clinics
• Clinical Research Laboratories
• Academic Institutes

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

• The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.
• Key Questions Answered in This Report
• 1. What was the size of the global plasma fractionation market in 2022?
• 2. What is the expected growth rate of the global plasma fractionation market during 2023-2028?
• 3. What has been the impact of COVID-19 on the global plasma fractionation market?
• 4. What are the key factors driving the global plasma fractionation market?
• 5. What is the breakup of the global plasma fractionation market based on the product?
• 6. What is the breakup of the global plasma fractionation market based on the sector?
• 7. What is the breakup of the global plasma fractionation market based on the application?
• 8. What is the breakup of the global plasma fractionation market based on the end user?
• 9. What are the key regions in the global plasma fractionation market?
• 10. Who are the key players/companies in the global plasma fractionation market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Plasma Fractionation Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Immunoglobulins
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Albumin
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Coagulation factor VIII
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Coagulation factor IX
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Sector

• 7.1 Private Sector
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Public Sector
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Neurology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Immunology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Hematology
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Other Applications
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Clinical Research Laboratories
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Academic Institutes
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 ADMA Biologics
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
  • 15.3.2 Bio Products Laboratory Ltd.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Boccard
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Grifols, S.A.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Hemarus Therapeutics Limited
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Intas Pharmaceuticals Limited
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 LFB S.A.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Merck Group
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Octapharma AG
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 SWOT Analysis
  • 15.3.10 PlasmaGen BioSciences Pvt. Ltd.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 SK Plasma Co. Ltd.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Virchow Biotech Private Limited
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio

List of Figures

• Figure 1: Global: Plasma Fractionation Market: Major Drivers and Challenges
• Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion US$), 2017-2022
• Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion US$), 2023-2028
• Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2022
• Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2022
• Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2022
• Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2022
• Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2022
• Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 43: China: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 47: India: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 61: France: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
• Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2022
• Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
• Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
• Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Plasma Fractionation Market: Key Industry Highlights, 2022 and 2028
• Table 2: Global: Plasma Fractionation Market Forecast: Breakup by Product (in Million US$), 2023-2028
• Table 3: Global: Plasma Fractionation Market Forecast: Breakup by Sector (in Million US$), 2023-2028
• Table 4: Global: Plasma Fractionation Market Forecast: Breakup by Application (in Million US$), 2023-2028
• Table 5: Global: Plasma Fractionation Market Forecast: Breakup by End User (in Million US$), 2023-2028
• Table 6: Global: Plasma Fractionation Market Forecast: Breakup by Region (in Million US$), 2023-2028
• Table 7: Global: Plasma Fractionation Market: Competitive Structure
• Table 8: Global: Plasma Fractionation Market: Key Players